ANDA Stability Final Guidance Arrives With Few Answers for Industry
This article was originally published in The Tan Sheet
With few changes from the draft and without the promised question-and-answer document, industry may still clamor for more. FDA recommends generic drug manufacturers follow the stability testing recommendations in International Conference on Harmonization guidances.
You may also be interested in...
The agency advises sponsors to follow the stability testing recommendations in the International Conference on Harmonization guidances; three companies submit comments seeking clarification from FDA.
Commissioner’s comments were yet another sign that US FDA won’t clear a vaccine ahead of the election, but hours later the president suggests the White House may decline to clear the agency’s new guidance on emergency use authorization standards for COVID-19 vaccines, raising new concerns about political interference in any decisions.
While neither party is likely to make any big policy changes this year, the action from both sides of the aisle indicates politicians still see going after pharma as a winning issue with voters even as polls show voters are focused elsewhere.